fashion -WSS

fashion

author：leisure time 2025-09-29 18:17:17 - browse：32275

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Hospital price transparency does save money, advocate argues

Wikipedia

WSS

Russian court extends detention of American musician

STAT Summit: How a Chicago ER doctor tackles gun violence

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

First Opinion Podcast: Long Covid needs a new approach

Rock icon Freddie Mercury pre

HHS leader on health, climate change and biopharma emissions

explore

fashion

hotspot

Bright Health sells Medicare Advantage business to Molina

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Jerome Adams on the need for new antivirals for Covid

HHS leader on health, climate change and biopharma emissions

United colonoscopy coverage change 'may cost lives,' doctors say

Pharma needs to include young adults in clinical research

Wildfire smoke exposes gaps in outdoor worker protections

Beam Therapeutics to lay off 20% of its staff, re

DIEP, the 'gold standard' of breast reconstruction, is under threat

Senate committee scrutinizes Medicare Advantage brokers

Wikipedia

Prosecutors seek bail revocation for FTX founder Sam Bankman

Scientists find bacteria from stomach of ancient iceman

Medical mystery: When an infection after surgery isn’t what it seems

How climate

Eli Lilly expects to double planned employment in Boston center

Impact of Dobbs ruling felt at reproductive medicine meeting

Wikipedia

knowledge

hotspot

knowledge